Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|November 10, 2015
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromesR Devillier, S Bramanti, S Fürst, et al.
Leukemia|August 22, 2003
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimenM Mohty, W Jacot, C Faucher, et al.
Journal of Hematotherapy|December 1, 1996
Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recoveryC Faucher, A G Le Corroller, C Chabannon, et al.
Leukemia & Lymphoma|December 30, 1998
A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemiaD Maraninchi, N Vey, P Viens, et al.
Leukemia Research|December 20, 2011
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?R Itzykson, S Thépot, O Beyne-Rauzy, et al.
Leukemia|December 17, 2005
Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trialsN Dhédin, H Dombret, X Thomas, et al.
Leukemia Research|January 15, 2008
Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomideC Kelaidi, S Park, S Brechignac, et al.
Leukemia|July 6, 2007
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trialE Tavernier, J-M Boiron, F Huguet, et al.
European Journal of Haematology|November 30, 2023
Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patientsC Petit, C Saillard, B Mohty, et al.
Leukemia|February 19, 2011
A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS studyP Chevallier, M Labopin, P Turlure, et al.
Pageof 7